We are excited to announce our participation in Antibody Engineering & Therapeutics (AET) USA 2024, happening in San Diego from December 15th to 18th. This premier event is dedicated to advancing antibody discovery, engineering, and therapeutics, offering unparalleled opportunities for collaboration, networking, and learning. Featuring 200+ expert speakers and attracting over 1,000 attendees, the conference showcases 150+ sessions. Attendees can explore cutting-edge innovations, connect with key decision-makers, and engage in focused discussions to accelerate the development of next-generation antibody therapeutics.
What is Advanced Therapies USA?
The Antibody Engineering & Therapeutics (AET) conference is a premier annual event that brings together scientists, researchers, and industry professionals from biotechnology and pharmaceutical sectors to explore advancements in antibody-based therapeutics. This conference focuses on cutting-edge research, innovation, and development strategies in antibody engineering, bispecifics, antibody-drug conjugates (ADCs), immune-oncology, and more.
Event Overview
Venue: Marriott Marquis San Diego, 333 W Harbor Dr, San Diego, CA 92101
Dates: December 15-18, 2024
- Conference Day 1: Sunday, December 15, 2024, 8:30 AM - 6:00 PM
- Conference Day 2: Monday, December 16, 2024, 8:00 AM - 5:00 PM
- Conference Day 3: Tuesday, December 17, 2024, 8:00 AM - 7:15 PM
- Conference Day 4: Wednesday, December 18, 2024, 8:00 AM - 7:45 PM
Booth #405
Event Schedule
The Antibody Engineering & Therapeutics (AET) USA 2024 agenda offers four days filled with insightful keynotes, expert-led track sessions, and interactive panel discussions. Topics include antibody discovery, bispecific and multi-specific antibodies, ADCs, immune-oncology, and machine learning in antibody development. For a complete overview, explore the full AET USA 2024 agenda.
Day 1: Sunday, December 15, 2024
- Pre-Conference Training Course from 8:30 AM to 5:00 PM
- Early Career Scientists Session from 10:00 AM to 12:00 PM
- Pre-Conference Workshops from 1:00 PM to 4:45 PM
Day 2: Monday, December 16, 2024
- Registration and Breakfast from 7:00 AM to 8:00 AM
- Welcome and Opening Remarks from 8:00 AM to 8:05 AM
- Keynote Presentations from 8:05 AM to 10:05 AM
- Networking Refreshment Break from 10:05 AM to 10:35 AM
- Scientific Presentations from 10:35 AM to 12:10 PM
- Luncheon Briefings from 12:15 PM to 1:15 PM
- Afternoon Presentations from 1:15 PM to 3:15 PM
- Networking Refreshment Break from 3:15 PM to 3:45 PM
- Future Perspectives in Antibody Therapeutics from 3:45 PM to 4:30 PM
- Closing Keynote on AI for Antibody Discovery from 4:30 PM to 5:15 PM
- Welcome Reception from 5:15 PM to 6:30 PM
Day 3: Tuesday, December 17, 2024
- Sunrise Yoga from 6:30 AM to 7:15 AM
- Registration from 7:15 AM to 7:30 AM
- Scientific Breakfast Briefings from 7:30 AM to 8:00 AM
- Morning Tracks from 8:15 AM to 9:45 AM
- Track 1: Novel Bispecific Antibodies: DuoBody studies, BiCE™ platform, extracellular protein degradation.
- Track 2: Antibodies for Metabolic Disease: Na+/K+ ATPase targeting, GDF-15 neutralization, novel metabolic targets.
- Networking Refreshment Break from 9:45 AM to 10:30 AM
- Mid-Morning Presentations from 10:30 AM to 12:00 PM
- Networking Luncheon, Exhibit, and Poster Viewing from 12:35 PM to 1:45 PM
- Afternoon Tracks from 2:30 PM to 4:00 PM
- Track 1: Cell Engagers: Combination strategies, co-stimulatory bispecifics, advanced T-cell engagers with CD2 costimulation.
- Track 2: Autoimmunity: Briquilimab, Obexelimab, forced proximity and cotargeting for autoimmune therapy
- Networking Refreshment Break from 4:00 PM to 4:45 PM
- Evening Tracks from 4:45 PM to 6:15 PM
- Track 1: Cell Engagers: IgM T-cell engagers, engineered IgA, tumor-microenvironment activated therapeutics.
- Track 2: Autoimmunity: DNTH103 for neuromuscular diseases, engineered regulatory T-cell therapy.
- Networking Reception from 6:15 PM to 7:15 PM
Day 4: Wednesday, December 18, 2024
- Fun Run from 6:30 AM to 7:15 AM
- Registration from 7:15 AM to 7:30 AM
- Scientific Breakfast Briefings from 7:30 AM to 8:00 AM
- Morning Tracks from 8:15 AM to 9:45 AM
- Track 1: In Vitro Antibody Discovery: Functional antibody selection, discovery for membrane targets.
- Track 2: Unusual Antibody Formats: Multispecific fusion proteins, cow ultralong CDR3 knobs.
- Networking Refreshment Break from 9:45 AM to 10:30 AM
- Mid-Morning Presentations from 10:30 AM to 12:00 PM
- Networking Luncheon from 12:35 PM to 1:45 PM
- Afternoon Tracks from 2:15 PM to 3:45 PM
- Track 1: In Vivo Antibody Discovery: High-throughput screening, affinity maturation, allergy-reversal antibodies.
- Track 2: ADC Technologies: MYTX-011 ADC, hybrid mechanistic modeling, Fc effector profiling
- Networking Refreshment Break from 3:45 PM to 4:15 PM
- Closing Presentations from 4:15 PM to 5:45 PM
About KACTUS
KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 2500 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.
